Skip to main content

Voyager Therapeutics, Inc.

VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001640266

No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 16, 2026
$101.4M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +2 vs. previous quarter
137
13F valueReported value at the end of Q2 2026
$122.7M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$40.4M
−49.5% year over year
Net income, FY2025
-$119.7M
No comparable prior period
Free cash flow, FY2025
-$135.1M
No comparable prior period
Revenue, Q3 FY2026
$4.01M
−70.0% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $119.7M (296.5% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
4.38M
Shares sold short
Change
+738.7K
+20.3% vs. previous
Days to cover
4.10
At average daily volume

Superinvestors holding VYGR, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding VYGR at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Voyager Therapeutics, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 3, 2026 (view filing)Apr 21 daySandrock AlfredPresident and CEOSSale−11.5K$3.87−$44.5K−2.4%472.5K after10b5-1
Feb 26, 2026 (view filing)Feb 242 daysSwartz RobinCOO & CBOSSale−6.46K$3.77−$24.3K−3.1%199.7K after10b5-1
Feb 26, 2026 (view filing)Feb 242 daysSandrock AlfredPresident and CEOSSale−14.2K$3.79−$53.8K−2.8%484.1K after10b5-1
Feb 26, 2026 (view filing)Feb 242 daysJorgensen Nathan D.Chief Financial OfficerSSale−4.67K$3.77−$17.6K−3.0%151.4K after10b5-1
Feb 26, 2026 (view filing)Feb 242 daysCarter Todd AlfredChief Scientific OfficerSSale−4.17K$3.76−$15.7K−2.8%145.7K after10b5-1
Feb 20, 2026 (view filing)Feb 182 daysSwartz RobinCOO & CBOSSale−3.88K$3.44−$13.4K−1.8%206.2K after10b5-1
Feb 20, 2026 (view filing)Feb 182 daysCarter Todd AlfredChief Scientific OfficerSSale−3.30K$3.44−$11.4K−2.2%149.9K after10b5-1
Feb 20, 2026 (view filing)Feb 182 daysSandrock AlfredPresident and CEOSSale−11.7K$3.41−$40.0K−2.3%498.3K after10b5-1
Feb 11, 2026 (view filing)Feb 101 daySwartz RobinCOO & CBOSSale−4.57K$3.85−$17.6K−2.1%210.1K after
Feb 11, 2026 (view filing)Feb 101 daySandrock AlfredPresident and CEOSSale−12.2K$3.78−$46.1K−2.3%510.0K after

Top 10 13F holders, Q2 2026

See all 137 holders

The largest institutional positions in Voyager Therapeutics, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding VYGR in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.5,172,063$18.1M0.00%−396,318−7.1%Reduced
Millennium Management LLC4,442,951$15.6M0.01%+1,014,380+29.6%Added
Armistice Capital, LLC3,436,000$12.0M0.33%−64,000−1.8%Reduced
Vestal Point Capital, LP2,625,000$9.19M0.21%−377,936−12.6%Reduced
Vanguard Capital Management LLC2,345,674$8.21M0.00%+62,421+2.7%Added
Geode Capital Management, LLC1,330,492$4.66M0.00%+280,514+26.7%Added
Opaleye Management Inc.1,185,000$4.15M0.38%+35,000+3.0%Added
State Street Corp1,076,422$3.77M0.00%+128,196+13.5%Added
Two Sigma Investments, LP948,517$3.32M0.00%+332,857+54.1%Added
Dimensional Fund Advisors LP838,184$2.93M0.00%−37,384−4.3%Reduced

Holders of 5% or more of VYGR

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Voyager Therapeutics, Inc..

Largest holders of VYGR from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Armistice Capital, LLC13G/A8.65%4.80M shares–Aug 14, 20251 filingAug 14, 2025SEC
Integrated Core Strategies (US) LLC13G/A7.40%4.44M shares+1.30 ppfrom 6.10%Jan 26, 20262 filingsJul 31, 2026SEC
BlackRock, Inc.13G/A6.40%3.53M shares–Apr 24, 20251 filingApr 24, 2025SEC
Armistice Capital, LLC13G6.28%3.87M shares+5.02 ppfrom 1.26%Feb 16, 202113 filingsNov 16, 2026SEC